Commercialization
COMMERCIALIZATION & COLLABORATION

Commercialization

Driving Innovations from Lab to Market

Active Ventures

DEVICE
SLOPE
Structured Light Observation and Perception Evaluation Device for the Assessment of Macular Health
DEVICE
Eye-on-a-Chip
Eye-on-a-chip Device
SOFTWARE
ObstAR
Augmented Reality (AR) Software Built to Aid the Visually Impaired
THERAPEUTICS
Viromids
A Redosable, Low-Cost Gene-Delivery Platform for Ocular Therapy
THERAPEUTICS
FlavoTear
Baicalein A Novel Disease Platform for Ocular Therapy
THERAPEUTICS
MimetiCore
Biomimetics Nanoplatform for the Treatment of Retinal Diseases

Precision Solutions
Across the Vision Care Continuum

From early detection devices to life-changing therapeutics
and assistive software.

SLOPE: Structured Light Observation and Perception Evaluation Device for the Assessment of Macular Health
Device

SLOPE: Structured Light Observation and Perception Evaluation Device for the Assessment of Macular Health

Harnessing quantum optics to detect the early-stage age-related macular degeneration

LEARN MORE
Eye-on-a-chip Device
Device

Eye-on-a-chip Device

Rapid, cost-effective, and eye-mimicking testing solution for researchers and pharma

LEARN MORE
ObstAR: Augmented Reality (AR) Software Built to Aid the Visually Impaired
Software

ObstAR: Augmented Reality (AR) Software Built to Aid the Visually Impaired

AR navigation aid for individuals with low vision

LEARN MORE
Viromids: A Redosable, Low-Cost Gene-Delivery Platform for Ocular Therapy
Therapeutics

Viromids: A Redosable, Low-Cost Gene-Delivery Platform for Ocular Therapy

Scalable, immune-silent viral vectors for targeted ocular therapy

LEARN MORE
FlavoTear: Baicalein - A Novel Disease Platform for Ocular Therapy
Therapeutics

FlavoTear: Baicalein - A Novel Disease Platform for Ocular Therapy

A Bioactive plant-derived flavonoid offers a multifunctional therapeutic solution for dry eye diseases

LEARN MORE
Mimeticore: Biomimetics Nanoplatform for the Treatment of Retinal Diseases
Therapeutics

Mimeticore: Biomimetics Nanoplatform for the Treatment of Retinal Diseases

Precise biorecognition to target and deliver drugs directly to sites of neuroinflammation in the retina, facilitating more controlled drug release

LEARN MORE
Collaborate
with CEVR